Allogeneic Adipose-Derived Mesenchymal Stem Cells
Diabetic Foot Ulcer
Medical University of WarsawCell therapyPhase 2Active
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Diabetic Foot Ulcer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyteal Charles University, Czech Republic | Phase 4 | BB |
Sevoflurane Charles University, Czech Republic | Phase 4 | BB |
Oxygen Jay C. Buckey Jr. | Phase 4 | BB |
Peripheral Blood Mononuclear Cell Mahidol University | Phase 3 | BB |
PEGYLATED CARBOXYHEMOGLOBIN BOVINE Prolong Pharmaceuticals | Phase 2 | B |
View all 10 →
Same molecule, other indications
Allogeneic Adipose-Derived Mesenchymal Stem Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →